ABVC BioPharma, Inc. (ABVC)

0.9601 -0.04 (-3.99%) USD  |  NASDAQ  |  Sep 04, 16:00
0.9471 -0.01 (-1.35%) After-Hours: 20:00
More

ABVC BioPharma SG&A Expense (TTM) : 6.400M for June 30, 2026

SG&A Expense (TTM) Chart

View SG&A Expense (TTM) for ABVC.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View SG&A Expense (TTM) Chart
Start Trial

Historical SG&A Expense (TTM) Data

View and export this data back to 2002. Start Trial.
Date Value
June 30, 2026 6.400M
March 31, 2026 7.905M
December 31, 2025 7.030M
September 30, 2025 5.164M
June 30, 2025 3.531M
March 31, 2025 2.323M
December 31, 2024 5.035M
September 30, 2024 6.483M
June 30, 2024 8.182M
March 31, 2024 8.741M
December 31, 2023 7.004M
September 30, 2023 7.212M
June 30, 2023 8.654M
March 31, 2023 8.860M
December 31, 2022 13.10M
September 30, 2022 12.95M
June 30, 2022 11.21M
March 31, 2022 10.79M
September 30, 2021 9.634M
June 30, 2021 9.091M
March 31, 2021 8.660M
December 31, 2020 8.420M
September 30, 2020 4.644M
June 30, 2020 4.424M
March 31, 2020 3.726M
Date Value
December 31, 2019 3.092M
September 30, 2019 2.521M
June 30, 2019 1.822M
March 31, 2019 1.711M
December 31, 2018 1.618M
September 30, 2018 1.544M
June 30, 2018 1.862M
March 31, 2018 1.565M
December 31, 2017 1.324M
September 30, 2017 1.665M
June 30, 2017 1.294M
December 31, 2016 1.231M
September 30, 2016 1.047M
June 30, 2016 0.4312M
March 31, 2016 0.1436M
December 31, 2015 0.0357M
September 30, 2015 0.0351M
June 30, 2015 0.0274M
March 31, 2015 0.0259M
December 31, 2014 0.0251M
September 30, 2014 0.0241M
June 30, 2014 0.0001M
March 31, 2014 0.0194M
December 31, 2013 0.0406M
September 30, 2013 0.185M

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
Anika Therapeutics, Inc. 52.67M
Perspective Therapeutics, Inc. 29.46M
MiMedx Group, Inc. 255.08M
Abbott Laboratories 13.94B
AngioDynamics, Inc. 157.09M